Cargando…

Sorafenib Neoadjuvant Therapy in the Treatment of High Risk Renal Cell Carcinoma

OBJECTIVE: To evaluate the clinical efficacy of sorafenib as preoperative neoadjuvant therapy in patients with high risk renal cell carcinoma (RCC). MATERIALS AND METHODS: Clinical data of 18 patients with high risk RCC who received surgery done successfully after preoperative neoadjuvant therapy wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yushi, Li, Yongqiang, Deng, Jianhua, Ji, Zhigang, Yu, Hongyan, Li, Hanzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315594/ https://www.ncbi.nlm.nih.gov/pubmed/25647522 http://dx.doi.org/10.1371/journal.pone.0115896

Ejemplares similares

Initial Experience of Sorafenib Neoadjuvant Therapy Combined with Retroperitoneoscopy in Treating T2 Large Renal Carcinoma
por: Lin, Chun-hua, et al.
Publicado: (2015)

iTRAQ-Based Quantitative Proteomic Analysis Identified HSC71 as a Novel Serum Biomarker for Renal Cell Carcinoma
por: Zhang, Yushi, et al.
Publicado: (2015)

Comparison of efficacy and safety among axitinib, sunitinib, and sorafenib as neoadjuvant therapy for renal cell carcinoma: a retrospective study
por: Cai, Wen, et al.
Publicado: (2019)

Metastatic renal clear cell carcinoma to the rectum, lungs, ilium, and lymph nodes: A case report
por: Zheng, Guoyang, et al.
Publicado: (2017)

Renal cell carcinoma and the use of sorafenib
por: Larkin, James MG, et al.
Publicado: (2006)

Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma
por: Kapoor, A., et al.
Publicado: (2009)

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer
por: Danilovic, Debora L. S., et al.
Publicado: (2018)

Efficacy of sequential therapies with sorafenib-sunitinib versus sunitinib-sorafenib in metastatic renal cell carcinoma: A systematic review and meta-analysis
por: Wen, Tingyu, et al.
Publicado: (2017)

Sorafenib in the management of metastatic renal cell carcinoma
por: Guevremont, C., et al.
Publicado: (2009)

Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
por: Ye, Ding-Wei, et al.
Publicado: (2014)

Laparoscopic resection of a paraganglioma behind the retrohepatic segment of the inferior vena cava: a case report and literature review
por: Wang, Wenda, et al.
Publicado: (2023)

Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer
por: Qiu, Juhui, et al.
Publicado: (2019)

Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial
por: Procopio, G, et al.
Publicado: (2011)

Skeletal Muscle Metastasis From Renal Cell Carcinoma: A Case Series and Literature Review
por: Sun, Juan, et al.
Publicado: (2022)

Sequential Treatment Based on Sunitinib and Sorafenib in Patients with Metastatic Renal Cell Carcinoma
por: Schlemmer, Marcus, et al.
Publicado: (2019)

Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapies
por: Roderburg, Christoph, et al.
Publicado: (2020)

Sorafenib improves the postoperative effect of early stage renal cell carcinoma
por: Liu, Taiyang, et al.
Publicado: (2016)

Successful treatment with sorafenib for sunitinib‐refractory metastatic papillary renal cell carcinoma: Potential impact of Raf overexpression on predicting the efficacy of sorafenib
por: Morinaga, Ryota, et al.
Publicado: (2018)

Comparative Metabolomic Profiling of Hepatocellular Carcinoma Cells Treated with Sorafenib Monotherapy vs. Sorafenib-Everolimus Combination Therapy
por: Zheng, Jian-feng, et al.
Publicado: (2015)

Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
por: Mousa, Ali Ben
Publicado: (2008)

Sorafenib for the treatment of unresectable hepatocellular carcinoma
por: Furuse, Junji
Publicado: (2008)

Pituitary metastasis from a renal cell carcinoma progressed after sorafenib treatment
por: Yang, Lin, et al.
Publicado: (2013)

Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
por: Randrup Hansen, Caroline, et al.
Publicado: (2017)

Successful treatment of aortic dissection during sorafenib therapy for hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer()()
por: Choi, Kyung Hwa, et al.
Publicado: (2018)

Neoadjuvant Therapy for Hepatocellular Carcinoma
por: Yin, Zongyi, et al.
Publicado: (2022)

Synergistic Antitumor Effect of Sorafenib in Combination with ATM Inhibitor in Hepatocellular Carcinoma Cells
por: Liu, Jianhua, et al.
Publicado: (2017)

Retroperitoneal Laparoscopic Management of Paraganglioma: A Single Institute Experience
por: Xu, Weifeng, et al.
Publicado: (2016)

Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localised Clear-Cell Renal Cell Carcinoma
por: Voylenko, O. A., et al.
Publicado: (2021)

Clinical experience and critical evaluation of the role of sorafenib in renal cell carcinoma
por: Zustovich, Fable, et al.
Publicado: (2011)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC
por: Liu, Xiaoyan, et al.
Publicado: (2019)

Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
por: Almhanna, Khaldoun, et al.
Publicado: (2009)

Use of Adjuvant Sorafenib in Liver Transplant Recipients with High-Risk Hepatocellular Carcinoma
por: Shetty, Kirti, et al.
Publicado: (2014)

Targeted inhibition of ACLY expression to reverse the resistance of sorafenib in hepatocellular carcinoma
por: Sun, Hong, et al.
Publicado: (2022)

Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
por: Lee, Sangheun, et al.
Publicado: (2013)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
por: Wu, Fei-Xiang, et al.
Publicado: (2017)

Neoadjuvant Therapy in High-Risk Prostate Cancer
por: Ashrafi, Akbar N., et al.
Publicado: (2020)

Neoadjuvant Immunotherapy in the Treatment of Renal Cell Carcinoma: A Case Series
por: Hess, Kevin J, et al.
Publicado: (2022)

Metastatic renal cell carcinoma: the first report of unilateral fundus hemorrhage induced by sorafenib
por: Li, Zhi Yong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_tgsb9719he5cm9sa08lslob55q